apo-ambrisentan tablet
apotex inc - ambrisentan - tablet - 5mg - ambrisentan 5mg - vasodilating agents
apo-ambrisentan tablet
apotex inc - ambrisentan - tablet - 10mg - ambrisentan 10mg - vasodilating agents
ambrisentan accord 10 mg film-coat. tabl.
accord healthcare b.v. - ambrisentan 10 mg - film-coated tablet - 10 mg - ambrisentan 10 mg - ambrisentan
ambrisentan accord 5 mg film-coat. tabl.
accord healthcare b.v. - ambrisentan 5 mg - film-coated tablet - 5 mg - ambrisentan 5 mg - ambrisentan
volibris 5 mg film-coated tablet
glaxo saudi arabia ltd., saudi arabia - ambrisentan - film-coated tablet - 5 mg
volibris 10 mg film-coated tablet
glaxo saudi arabia ltd., saudi arabia - ambrisentan - film-coated tablet - 10 mg
ambrisentan sandoz 5 mg film-coat. tabl.
sandoz sa-nv - ambrisentan 5 mg - film-coated tablet - 5 mg - ambrisentan 5 mg - ambrisentan
ambrisentan sandoz 10 mg film-coat. tabl.
sandoz sa-nv - ambrisentan 10 mg - film-coated tablet - 10 mg - ambrisentan 10 mg - ambrisentan
ambrisentan teva 10 mg
abic marketing ltd, israel - ambrisentan - film coated tablets - ambrisentan 10 mg - ambrisentan - ambrisentan is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment with tadalafil. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.
ambrisentan teva 5 mg
abic marketing ltd, israel - ambrisentan - film coated tablets - ambrisentan 5 mg - ambrisentan - ambrisentan is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment with tadalafil. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.